Skip to main content

Animations

MJFF Publications

4601 - 4610 of 8673 Results
Title
Year
  • Year
  • 2024
  • 2018
  • 2016
  • 2018
  • 2022
  • 2024
  • 2024
  • 2023
  • 2023
  • 2017
  • Summary Details
    RESTRICTED
    Title: Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse models
    Journal Name: Molecular Therapy - Nucleic Acids
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.omtn.2024.102251
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s disease
    Journal Name: PeerJ
    Publisher: PeerJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7717/peerj.5539
    Citation Count: 19
  • Summary Details
    OPEN
    Title: LRRK2 deficiency impacts ceramide metabolism in brain
    Journal Name: Biochemical and Biophysical Research Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbrc.2016.08.082
    Citation Count: 58
  • Summary Details
    RESTRICTED
    Title: An mGlu4‐PositiveAllostericModulatorAlleviatesParkinsonism inPrimates
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27462
    Best OA location URL:
    Citation Count: 52
  • Summary Details
    OPEN
    Title: LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00354-3
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Identification and structural characterization of small molecule inhibitors of PINK1
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-58285-3
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial
    Journal Name: eClinicalMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.eclinm.2024.102474
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late‐onset cerebellar ataxia
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ene.16039
    Best OA location URL:
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease Models
    Journal Name: Antioxidants
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/antiox12030582
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0186508
    Citation Count: 39
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.